Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials - Top-Institutions - MDSpire

Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials

  • By

  • Agathoklis Efthymiadis

  • Konstantinos Tsikopoulos

  • Edouard G Mills

  • Andrew Milne

  • Waljit S Dhillo

  • Ali Abbara

  • Alexander N Comninos

  • January 8, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Women's Health

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Rheumatology
    • Bone Health

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Gynecology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Women’s Health

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrinology
    • Orthopedics
    • Bone Health

Original Source(s)

Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials

  • by Agathoklis Efthymiadis, Konstantinos Tsikopoulos, Edouard G Mills, Andrew Milne, Waljit S Dhillo, Ali Abbara, Alexander N Comninos

  • January 8, 2026

Related Content

Multimodal Progressive Fusion Model for Predicting Hip Fracture Risk in the Elderly: The MMPro-HIP Approach

Case Report: Tibial plateau fracture in Charcot neuroarthropathy: a report of two cases with contrasting outcomes

MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss